未找到相关数据
Real-world (RW) study in patients (pts) with metastatic colorectal cancer (mCRC) with long-term responses to regorafenib in the USA.
被引：0
作者：
Kim, Richard D.
Pan, Xiaoyun
Ostojic, Helene
Zhang, Yiqiao
Lunacsek, Orsolya
Pisa, Federica
Peeters, Marc
机构：
[1] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA
[2] Bayer HealthCare Pharmaceut Inc, Real World Evidence Oncol, Whippany, NJ USA
[3] Bayer Consumer Care AG, Basel, Switzerland
[4] Bayer HealthCare Pharmaceut, Whippany, NJ USA
[5] Bayer AG, Real World Evidence Oncol, Berlin, Germany
[6] Antwerp Univ, Antwerp Univ Hosp, Edegem, Belgium
关键词：
281-5277-2622-5397;
281-318-9499;
283-237-255;
3282-206-4957-326-5009-2386;
4;
3;
2;
182;
250;
38092-25821;
38092-20285;
38092-18849;
D O I：
10.1200/JCO.2024.42.3_suppl.48
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：48 / 48
页数：1
相关论文